Clinical Trials Logo

Chalazion clinical trials

View clinical trials related to Chalazion.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04342507 Completed - Chalazion Clinical Trials

Probiotics for Treatment of Chalazion in Adults

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

There is growing evidence encouraging probiotics use in several diseases. The aim of the investigator's study is to define the possible beneficial impact of probiotics on adults suffering from chalazia.

NCT ID: NCT04322500 Completed - Chalazion Clinical Trials

Probiotics for Chalaziosis Treatment in Children

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

There is growing evidence encouraging the use of probiotics in many conditions in children. The aim of the investigator's study is to define the possible beneficial impact of probiotics on paediatric patients affected by chalaziosis.

NCT ID: NCT03248440 Completed - Chalazion Clinical Trials

Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion

SUNRISE
Start date: July 31, 2017
Phase: Phase 3
Study type: Interventional

This protocol for SUN-131 1.5% TDS is developed for the treatment of chalazion. SUN-131 1.5% TDS is designed for local delivery of a corticosteroid, to the upper or lower eyelid. The purpose of this study is to evaluate the efficacy and safety of SUN-131 1.5% TDS as compared with placebo TDS in the treatment of a chalazion.

NCT ID: NCT02338648 Completed - Chalazion Clinical Trials

Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion

Start date: October 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of SUN-131 1.5% TDS as compared with placebo TDS in the treatment of chalazion based on the proportion of subjects that have complete response. Complete response is defined as the absence of any significant clinical signs of a chalazion with possible scaring or skin defects resulting from healing of the chalazion allowed.

NCT ID: NCT01230593 Completed - Clinical trials for Chalazion Left Eye, Unspecified Eyelid

Chalazion Conservative Treatment Trial

Start date: November 2010
Phase: N/A
Study type: Interventional

An eyelid stye, or chalazion, is the most common eyelid ailment, and is caused by the blockage of one of the oil secreting glands of the eyelid (meibomian glands). This leads to a typically painful, swollen, and red eyelid bump that lasts from days to weeks and months. The chalazion may cause tearing, pressure on the cornea, and irritation, all of which contribute to its morbidity. There are many anecdotal first line treatments for this condition, including warm compresses to the eyelid, topical antibiotics, topical steroids, topical combination antibiotic/steroid, and oral antibiotics. There have been no clinical trials to compare the efficacy of any of these conservative treatments. We wish to determine the most effective conservative medical treatment for chalazia.

NCT ID: NCT01202747 Completed - Dry Eye Syndromes Clinical Trials

Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction

Start date: September 2010
Phase: Phase 2/Phase 3
Study type: Interventional

The objective is to evaluate the feasibility of using additional screening methods to optimize effectiveness outcomes with the LipiFlow System for application of heat and pressure therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction, also known as evaporative dry eye or lipid deficiency dry eye, and chalazia. The screening methods include diagnostic expression of the meibomian glands and interferometry assessment of the tear film.

NCT ID: NCT00832130 Completed - Dry Eye Syndromes Clinical Trials

Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye

Start date: February 2009
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the clinical utility, safety and effectiveness of the Manual Mini System compared to standardized warm compress therapy for application of controlled, localized heat therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction, also known as evaporative dry eye or lipid deficiency dry eye, and chalazia.

NCT ID: NCT00420628 Completed - Chalazion Clinical Trials

Pediatric Zylet Safety and Efficacy Study

Start date: November 2006
Phase: Phase 4
Study type: Interventional

A multicenter study to evaluate the safety and efficacy of Zylet compared to vehicle in children aged 0-6 for the management of lid inflammation (chalazion/hordeolum)